Edition:
India

Novelion Therapeutics Inc (NVLN.OQ)

NVLN.OQ on NASDAQ Stock Exchange Global Select Market

3.31USD
1:30am IST
Change (% chg)

$-0.23 (-6.50%)
Prev Close
$3.54
Open
$3.54
Day's High
$3.54
Day's Low
$3.31
Volume
18,005
Avg. Vol
23,068
52-wk High
$7.27
52-wk Low
$2.97

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 31.90 -1.667
Mar '18 27.48 -1.755
FY 2017 Dec '17 38.91 -1.316
Sep '17 28.67 -2.668
Jun '17 40.88 -1.152
Mar '17 29.98 -1.670
FY 2016 Dec '16 13.57 -1.482
Sep '16 0.00 -0.562
Jun '16 0.00 -0.485
Mar '16 0.00 -2.072
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 2 35.15 36.10 34.20 --
Quarter Ending Dec-18 2 42.40 43.60 41.20 --
Year Ending Dec-18 2 136.95 137.20 136.70 160.65
Year Ending Dec-19 2 167.60 187.90 147.30 189.20
Earnings (per share)
Quarter Ending Sep-18 2 -0.71 0.07 -1.49 --
Quarter Ending Dec-18 2 -0.56 0.16 -1.27 --
Year Ending Dec-18 2 -4.69 -3.20 -6.18 -1.21
Year Ending Dec-19 2 -2.53 1.30 -6.35 -0.43
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -112.47 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Novelion Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -0.42 -3.86 39 --
13 Week -24.41 -28.09 15 --
26 Week -33.93 -38.95 19 --
52 Week -31.41 -41.87 28 --
YTD -16.51 -26.68 30 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 83.01%
# of Holders: 66
Total Shares Held: 15,649,428
3 Mo. Net Change: 94,210
# New Positions: 8
# Closed Positions: 37
# Increased Positions: 17
# Reduced Positions: 53
# Net Buyers: -36
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.